Thompson Davis & Co’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-250
Closed -$11K 687
2017
Q3
$11K Hold
250
0.02% 654
2017
Q2
$10K Hold
250
0.02% 645
2017
Q1
$10K Hold
250
0.01% 678
2016
Q4
$10K Hold
250
0.02% 693
2016
Q3
$8K Sell
250
-1,000
-80% -$38K 0.01% 707
2016
Q2
$50K Hold
1,250
0.08% 239
2016
Q1
$42K Sell
1,250
-250
-17% -$7.15K 0.06% 269
2015
Q4
$47K Hold
1,500
0.07% 266
2015
Q3
$45K Sell
1,500
-750
-33% -$24.8K 0.06% 281
2015
Q2
$71K Buy
2,250
+1,000
+80% +$26.1K 0.08% 247
2015
Q1
$29K Buy
1,250
+250
+25% +$5.17K 0.03% 428
2014
Q4
$20K Sell
1,000
-11,750
-92% -$202K 0.02% 510
2014
Q3
$200K Buy
12,750
+12,250
+2,450% +$175K 0.26% 88
2014
Q2
$6K Sell
500
-250
-33% -$2.99K 0.01% 570
2014
Q1
$10K Hold
750
0.02% 482
2013
Q4
$11K Buy
+750
New +$10.2K 0.02% 436

Other funds holding AMN

Thompson Davis & Co's AMN Position: Q4 2017 in Review

Thompson Davis & Co sold out of AMN Healthcare (AMN) in Q4 2017, closing a stake of 250 shares — an estimated $11K sold.

Thompson Davis & Co first reported a position in AMN in Q4 2013 and held it in 16 quarters. The position peaked at $200K in Q3 2014. 291 funds tracked by Wall St. Rank hold AMN as of Q4 2017.

  • Thompson Davis & Co reported no remaining AMN Healthcare position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 250 AMN Healthcare shares in Q4 2017, an estimated $11K.
  • Thompson Davis & Co first reported a position in AMN Healthcare in Q4 2013 and held it in 16 quarters.
  • Thompson Davis & Co's AMN Healthcare position peaked at $200K in Q3 2014.
  • 291 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.